Pyridine-3-sulfonyl chloride hydrochloride → HCID 59513572, compound
Reaction equation
[CH3:1][O:2][C:3]1[C:4]([CH2:12][N:13]([CH3:15])[CH3:14])=[C:5]2[C:9](=[CH:10][CH:11]=1)[NH:8][CH:7]=[CH:6]2.Cl.[N:17]1[CH:22]=[CH:21][CH:20]=[C:19]([S:23](Cl)(=[O:25])=[O:24])[CH:18]=1>C(Cl)Cl>[CH3:1][O:2][C:3]1[C:4]([CH2:12][N:13]([CH3:14])[CH3:15])=[C:5]2[C:9](=[CH:10][CH:11]=1)[N:8]([S:23]([C:19]1[CH:18]=[N:17][CH:22]=[CH:21][CH:20]=1)(=[O:25])=[O:24])[CH:7]=[CH:6]2Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 1-(5-methoxy-1H-indol-4-yl)-N,N-dimethylmethanamine (30 mg, 0.15 mmol; Intermediate 97) and pyridine-3-sulfonyl chloride hydrochloride (43 mg, 0.20 mmol) in DCM (1 mL) 5 M NaOH (2 mL) was added. The reaction mixture was stirred at rt over night. The organic phase was collected and the solvent was removed under reduced pressure. Purification by preparative HPLC/UV (System B) afforded the title product (2 mg, 4%) as a white solid. MS (ESI+) for C17H19N3O3S m/z 346 (M+H)+.
Workup
- customThe organic phase was collected
- customthe solvent was removed under reduced pressure
- customPurification by preparative HPLC/UV (System B)
Sources & evidence
- ORD record
- ord-951d0908a8244d558858c1053699e1ef
- Source dataset
- uspto-grants-2010_10
- Patent number
- US07812017B2
Reaction notes
Loading…